1Abrahamian H, Endler G, Exner M, et aI. Association of Low - grade Inflammation with Nephropathy in Type 2Diabetic Patients: Role of Elevated CRP - levels and 2Different Gene - polymor?phisms of Proinflammatory Cytokines. Exp Clin Endocrinol Diabe?tes,2007, 115(1) :38 -41.
2Yang B, Hodgkinson A, Oates PJ, Millward BA, et al. High glucose induction of DNA - bindingactivity of the transcription factor NFkappaB in patients withdiabetic Nephropathy. Biochim Biophys?Acta,2oo8, 1782 :295 -302.
3Bertani T, Abbate M, Zoja C, et al. Tumor necrosisfactor induces glomerular damage in the rabbit, Am.J. Pathol. 134 (1989) 419 -430.
5Hirano T, Akira S, Taga T, et al. Biological and clinical aspects of interleukin 6 ,Immunol. Today, 1990 , 11 : 443 - 449.
6NavarroJF , Milena FJ , Mora C, et al. Renal pro - inflammatory cy?tokinegene expression in diabetic nephropathy: effect of angioten?sin - converting enzyme inhibitionand pentoxifylline administra?tion. AmJ Nephrol,2oo6,26:562 -570.
7Arababadi MK, Nosratabadi R, Hassanshabi G, et al. Nephropathic complication of type - 2 diabetes is following pattern of autoim?mune diseases? Diabetes Res. Clin. Pract. 87 (2010) 33 - 37.
10Hoshi S, Shu Y, Yoshida F, et al. Podocyte InjuryPromotes Pro?gressive Nephropathy in Zucker DiabeticFatty Rats. Lab Invest, 2002 ,82( 1) :25 -35.
二级参考文献22
1Bottinger EP, Bitzer M. TGF - β signaling in renal disease. J Am Soc Nephrol, 2002; 13 (10) : 2600 -2610
2Anna KO, Anna D, Johan K et al. VEGF receptor signalling - ill control of vascular function. Nat Rev Mol cell Biol, 2006; 7 (3): 359-371
3Sharma K, Ziyadeh FN. Renal hypertrophy is associated with upregulation of TGF - beta 1 gene expression in diabetic BB rat and NOD mouse. Am J Physiol, 1994; 267 (6): F1094 - F1101
4Hoshi S, Shu Y, Yoshida F et al. Podocyte injury promotes progressive nephropathy in zucker diabetic fatty rats. Lab Invest, 2002; 82 (1): 25-35
5Nakamura T, Ushiyama C, Suzuki Set al. Urinary excretion of polo - eytes in patients with diabetic nephropathy. Neprol Dial Tramplant, 2000; 15 (9) : 1379 - 1383
6Ina K, Kitamura H, Tatsukawa S et al. Transformation of interstitial fibroblasts and tuhulointerstitial fibrosis in diabetic nephropathy. Med Electron Microsc, 2002; 35 (2) : 87 -96
7Okazaki Y, Yamasaki Y. Enhanced TGF - β/smad signaling in the early stage of diabetic nephropathy is independent of the AT1a recepror. Japannese society of Nephrology, 2007; 11:77-87
8Whittle C, Gillespie K, Harrison R et al. Heterogeneous vascular endothelial growth factor (VEGF) isoform mRNA and receptor mRNA expression in human glomeruli, and the identification of VEGFI48 mRNA, a novel truncated splice variant. Clin Sei. 1999:97 (3) , 303 -312
9Cha DR, Kim NH, Yoon JW. Role of vascular endothelial growth factor in diabetic nephropathy. Kidney International, 2000; 58 (Supp177) : S104 - S112
10Senthil D, Choudhury GG, McLaurin C et al. Vascular endothelial growth factor induces protein synthesis in renal epithelial ceils: a potential in diabetic nephropathy. Kidney Int, 2003; 64 (2): 468-479
1Inoue K, Wada J, Eguchi J, et al. Urinary fetuin-A is a novel marker for diabetic nephropathy in type 2 diabetes identified by lectin microarray[ J]. PLoS One,2013,8(10) :77118-77119.
2Kanasaki K i Taduri G, Koya D. Diabetic nephropathy: the role of inflammation in fibroblast activation and kidney fibrosis [ J ]. Front Endocrinol (Lausanne),2013,4(2) :7-9.
3Ma J, Wu HL, Zhao CY, et al. Requirement for TLR2 in the de- velopment of albuminuria, inflammation and fibrosis in experimental diabetic nephropathy [ J ]. Int J Clin Exp Pathol, 2014,7(2) :481-495.
4Andy KH, Gregory H. Inflammation in Diabetic Nephropathy[ j]. Mediators Inflamm,2012,22 ( 7 ) : 96 -98.
